Deniz Gökengin

ORCID: 0000-0003-0704-2302
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • Sex work and related issues
  • HIV/AIDS Impact and Responses
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Adolescent Sexual and Reproductive Health
  • COVID-19 Clinical Research Studies
  • Reproductive tract infections research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and Mental Health
  • Brucella: diagnosis, epidemiology, treatment
  • Long-Term Effects of COVID-19
  • Hepatitis B Virus Studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Hepatitis C virus research
  • COVID-19 and healthcare impacts
  • Escherichia coli research studies
  • Pharmacological Effects and Toxicity Studies
  • Syphilis Diagnosis and Treatment
  • HIV/AIDS oral health manifestations
  • HIV, TB, and STIs Epidemiology
  • Migration, Health and Trauma

Ege University
2016-2025

Zero to Three
2024

Martel
2022

Izmir University
2022

Ege Üniversitesi Tıp Fakültesi Hastanesi
2022

Izmir Kâtip Çelebi University
2021

Office of Infectious Diseases
2005

IntroductionThe SARS-CoV-2 pandemic has hit the European region disproportionately. Many HIV clinics share staff and logistics with infectious disease facilities, which are now on frontline in tackling COVID-19. Therefore, this study investigated impact of current situation care continuity antiretroviral treatment (ART) supplies CEE countries.MethodsThe Euroguidelines Central Eastern Europe (ECEE) Network Group was established February 2016 to review standards for region. The group consists...

10.1016/j.ijid.2020.05.013 article EN cc-by-nc-nd International Journal of Infectious Diseases 2020-05-11

Testing for HIV is one of the cornerstones in fight against spread. The 2014 European Guideline on provides advice testing infection individuals aged 16 years and older who present to sexually transmitted infection, genito-urinary or dermato-venereology clinics across Europe. It may also be applied other clinical settings where required, particularly primary care settings. aim guideline provide practical guidance clinicians laboratories that within these undertake testing, indicate standards...

10.1177/0956462414531244 article EN International Journal of STD & AIDS 2014-04-22

This position statement is aimed at front-line clinical practitioners and public health authorities in WHO European Region providing services for people wishing to reduce their risk of acquiring sexually transmitted infections (STIs), including HIV.

10.1177/09564624241273801 article EN International Journal of STD & AIDS 2024-08-21

ABSTRACT: This survey produced baseline information about student knowledge of sexually transmitted diseases (STDs), their sexual attitudes, and behavior to help establish control education programs. The study was conducted at Ege University, Izmir, Turkey, during the 1999–2000 academic year. A total 2,217 first‐ fourth‐year students determined by stratified sampling constituted group. All who volunteered participate completed a questionnaire assessing sociodemographic factors, behavior,...

10.1111/j.1746-1561.2003.tb06575.x article EN Journal of School Health 2003-09-01

The number of new cases HIV infection has been decreasing in some parts the world (e.g. sub-Saharan Africa) with highest burden disease recent years. However, other regions are showing a different trend, such as Eastern Europe, Middle East, North Africa and Central Asia. This trend seems also to apply European region. article analyses data for Europe derived from annual surveillance reports Centre Disease Prevention Control (ECDC) gives an overview status epidemic this specific We show that,...

10.1016/s2055-6640(20)30459-3 article EN cc-by-nc-nd Journal of Virus Eradication 2016-07-01

Objective: The aim of this study was to analyze the temporal trends HIV epidemiology in Turkey from 2011 2016. Method: Thirty-four teams 28 centers at 17 different cities participated retrospective study. Participating were asked complete a structured form containing questions about epidemiologic, demographic and clinical characteristics patients presented with new diagnosis between Demographic data all (complete or partial) included analyses. For cascade care analysis, 15 that provided full...

10.2174/1570162x18666200427223823 article EN Current HIV Research 2020-04-28

Abstract Aim Coronavirus Disease 2019 (COVID‐19) changed the delivery of medical education in Turkey by moving to an emergency remote teaching system and led many challenges for future doctors. In this study, we aimed explore impact COVID‐19 pandemic on students, assess their anxiety level main sources related pandemic. Methods A Google Form was distributed students using virtual snowball sampling method. The form included Beck Anxiety Inventory additional 19 questions sociodemographic...

10.1111/ijcp.14139 article EN International Journal of Clinical Practice 2021-03-08

With no expected vaccine for HIV in the near future, we aimed to define current situation and challenges pre- post-exposure prophylaxis (PrEP PEP) Central Eastern Europe (CEE). The Euroguidelines CEE Network Group members were invited respond a 27-item survey including questions on PrEP (response rate 91.6%). was licensed 68.2%; 95 centers offered estimated number around 9000. It available daily (40.1%), on-demand (13.3%), or both forms (33.3%). access <1−80%. Three major barriers lack of...

10.3390/vaccines11010122 article EN cc-by Vaccines 2023-01-04

This study aimed to determine HIV incidence and prevalence in Turkey estimate the cost-effectiveness of improving testing diagnosis next 20 years.HIV has been rapidly increasing last decade with a particularly high rate infection for younger populations, which underscores urgent need robust prevention program improved capacity HIV.We developed dynamic compartmental model transmission progression among Turkish population aged 15-64 assessed effect diagnosis. The generated number new cases by...

10.1371/journal.pone.0286254 article EN cc-by PLoS ONE 2023-06-30

Objectives Overtly experienced HIV-related stigma is associated with depressive symptoms for people living HIV (PLWH). Research suggests that an important mediating mechanism in this association internalised stigma, where PLWH accept negative societal views about HIV, apply them to themselves and develop a view of themselves. Microaggressions are subtle indirect discriminatory behaviours and, like overtly may also contribute symptoms. We tested hypothesis examined the roles maladaptive ways...

10.1136/sextrans-2024-056354 article EN Sexually Transmitted Infections 2025-02-12

HIV-related stigma is a widespread experience among HIV-affected individuals that may have an impact on the well-being of both people living with HIV (PLWH) and associated individuals. This review examines multifaceted nature by summarizing its dimensions. Furthermore, it discusses how different dimensions intersectional due to co-existing stigmatized conditions can lead differential effects mental physical health outcomes PLWH. The scope this consists associations between challenges...

10.32552/2025.actamedica.1110 article EN Acta Medica 2025-03-18

Abstract Background There is limited evidence on the modification or stopping of antiretroviral therapy (ART) regimens, including novel drugs. The aim this study was to evaluate discontinuation first ART before and after availability better tolerated less complex regimens by comparing frequency, reasons associations with patient characteristics. Methods A total 3019 ART-naive patients registered in HIV-TR cohort who started between Jan 2011 Feb 2017 were studied. Only within year treatment...

10.1186/s12981-020-00328-6 article EN cc-by AIDS Research and Therapy 2021-01-09

One hundred and sixty-six presumed brucellosis patients were included in the study. These classified as primary (91), relapse (18) suspected (57) cases according to their clinical presentations, serologic microbiologic test results. Primary evaluated retrospectively age, sex, residence, routes of transmission, laboratory findings, treatment regimens, duration treatment, rates. Of 109 patients, 57 male 52 female. The ages ranged between 16-75 (mean age 40.2). percentages urban rural residence...

10.1177/004947550303300310 article EN Tropical Doctor 2003-07-01

Objectives The objective of this paper is to summarize the outcomes Euroguidelines in Central and Eastern Europe ( ECEE ) conference held Warsaw February 2016. main aim was facilitate a discussion on European AIDS Clinical Society EACS guidelines implementation across region neighbouring countries present current obstacles benchmarking HIV care Europe. Methods During 2‐day meeting, there were country‐based presentations using predefined template so as make data comparable focus discussion....

10.1111/hiv.12436 article EN HIV Medicine 2016-08-24

To study in vitro activities of three quinolones (ciprofloxacin, levofloxacin, moxifloxacin), four macrolides (erythromycin, dirithromycin, azithromycin, clarithromycin) and doxycycline against 44 clinical isolates Brucella melitensis.Forty-four B. melitensis strains were isolated from blood cultures adult patients with acute brucellosis who hospitalized the ward Department Clinical Microbiology Infectious Diseases. The minimum inhibitory concentrations (MICs) tested antimicrobials measured...

10.1159/000088122 article EN Medical Principles and Practice 2005-01-01

The aim of this descriptive article is to share the experience in Ege University, Turkey with favipiravir treatment severe SARS-CoV-2 pneumonia.This retrospective study included patients diagnosed COVID-19 who presented or developed pneumonia.Forty completed a full course (at least 5 days) were study. At baseline, 30 (75%) required for respiratory distress. Thirty-three (82.5%) discharged from hospital recovery, 6 (15%) died and 1 case (2.5%) was still at intensive care unit (ICU) when paper...

10.3906/sag-2008-33 article EN other-oa TURKISH JOURNAL OF MEDICAL SCIENCES 2020-11-25

(1) Background: Viral hepatitis C (HCV) and viral B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV A (HAV) treated for HCV. We aimed to compare testing, prophylaxis treatment of Central Eastern Europe (CEE) 2019 2022. (2) Methods: Data was collected through two on-line surveys conducted 2022 among 18 countries the Euroguidelines CEE (ECEE) Network Group. (3) Results: In all standard care screen HCV both years; screening HAV routine...

10.3390/vaccines11050980 article EN cc-by Vaccines 2023-05-14

10.5152/kd.2018.04 article EN Klimik Dergisi/Klimik Journal 2018-04-30
Coming Soon ...